Latest

Cutting Through The Fog: How Clear Communication Can Save Lives

Cutting Through The Fog: How Clear Communication Can Save Lives

Using the same methods they use to stimulate demand for a brand, agencies can educate communities and ultimately transform how countries approach healthcare, urges H.E. Toyin Saraki.

Video recap of the 2014 MM&M Awards

Video recap of the 2014 MM&M Awards

A highlight reel includes key moments from the Awards ceremony.

Consumers swayed by comparative drug claims: study

Consumers swayed by comparative drug claims: study

In a study to observe their effect in DTC ads, comparison claims in both print and video ads led consumers to trust those drugs over rival medications, researchers found.

Lilly sales fall, drugmaker to keep rep count low

Lilly sales fall, drugmaker to keep rep count low

Cymbalta and Evista patent losses drove down sales, but Lilly said it does not plan to replenish the sales force it thinned in anticipation of the decline.

Claims show BMS's Abilify remains strong

The antipsychotic's hold on the market has been steady, despite generics of drugs such as AstraZeneca's Seroquel.

App may diagnose glaucoma

Researchers say the iPad app could help assess vision loss.

Five things for pharma marketers to know: Thursday, October 23

Five things for pharma marketers to know: Thursday, October 23

FDA panel endorses Novartis psoriasis drug; court rules with Pfizer on cancer drug patent; drugmakers may look for indemnity against losses from Ebola vaccines.

Biogen's strong quarter eclipsed by patient death

Biogen's strong quarter eclipsed by patient death

Despite strong performance by its MS therapies, the drugmaker's robust third-quarter sales were overshadowed by the death of a patient taking Tecfidera.The patient had a rare brain infection.

GSK restructures, as respiratory disappoints

GSK restructures, as respiratory disappoints

GlaxoSmithKline's third-quarter sales fell 10% for the quarter, compared to last year, and new Ellipta products failed to cushion the 24% drop in US Advair sales.

NIH tests second Ebola vax in humans

Canada's National Microbiology Laboratory developed the vaccine, which has been licensed to NewLink Genetics Corp.

Agency Spotlight


Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.